Nab-paclitaxel and carboplatin combined with antiangiogenic drugs
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://data.mendeley.com/datasets/vdhjxp87mh
下载链接
链接失效反馈官方服务：
资源简介：
We retrospectively investigated the efficacy and toxicity of NCA regimen in unresectable stage IIIC or IV melanoma patients who progressed on previous therapy. The NCA regimen consisted of nab-paclitaxel (260 mg/m2) and carboplatin(AUC=5) on day 1 and bevacizumab, 5 mg/kg IV every 2 weeks or endostatin 7.5mg/m2 days 1-14,Q28.
创建时间：
2020-03-05
